Comprehensive Inpatient Psychiatric Assessment
Introduction to Assessment Components
- A comprehensive inpatient psychiatric assessment template should include standardized sections for history of present illness, psychiatric history, substance use, medical history, family history, personal/social history, mental status examination, physical examination findings, risk assessment, impression, and treatment plan as recommended by the American Psychiatric Association 1, 2, 3
Identifying Information
- Patient demographics (name, age, gender, date of birth) should be documented as part of the assessment process, according to the American Psychiatric Association 1
- Date and time of evaluation should be recorded, as per the American Psychiatric Association's guidelines 1
- Source of information (patient, family, medical records, etc.) should be noted, following the American Psychiatric Association's recommendations 1
Chief Complaint/Reason for Admission
- The patient's own words regarding the presenting problem should be documented, as suggested by the American Psychiatric Association 2
- Circumstances leading to hospitalization should be assessed, according to the American Psychiatric Association's guidelines 2
History of Present Illness
- A psychiatric review of systems should be conducted, as part of a comprehensive assessment, recommended by the American Psychiatric Association 2
- Anxiety symptoms and panic attacks should be evaluated, following the American Psychiatric Association's guidelines 2
- Sleep patterns and abnormalities, including sleep apnea, should be assessed, as suggested by the American Psychiatric Association 2
- Assessment of impulsivity should be performed, according to the American Psychiatric Association's recommendations 2
- Chronology of symptom development should be documented, as per the American Psychiatric Association's guidelines 1
Psychiatric History
- Past and current psychiatric diagnoses should be identified, following the American Psychiatric Association's guidelines 2
- Prior psychotic or aggressive ideas should be assessed, as suggested by the American Psychiatric Association 2
- Prior aggressive behaviors (homicide, domestic violence, threats) should be evaluated, according to the American Psychiatric Association's recommendations 2
- Prior suicidal ideas, plans, and attempts (including context, method, damage, lethality, intent) should be documented, as per the American Psychiatric Association's guidelines 2
Substance Use History
- Use of tobacco, alcohol, and other substances should be assessed, following the American Psychiatric Association's guidelines 2
- Misuse of prescribed or over-the-counter medications should be evaluated, as suggested by the American Psychiatric Association 2
- Current or recent substance use disorders should be identified, according to the American Psychiatric Association's recommendations 2
Medical History
- Allergies and drug sensitivities should be documented, as per the American Psychiatric Association's guidelines 2
- Current medications (prescribed, non-prescribed, supplements) should be listed, following the American Psychiatric Association's recommendations 2
- Primary care relationship should be assessed, as suggested by the American Psychiatric Association 2
- Past/current medical illnesses and hospitalizations should be evaluated, according to the American Psychiatric Association's guidelines 2
- Cardiopulmonary status should be assessed, as recommended by the American Psychiatric Association 3
- Endocrinological disease should be evaluated, following the American Psychiatric Association's guidelines 3
- Infectious diseases (STDs, HIV, tuberculosis, hepatitis C) should be identified, as suggested by the American Psychiatric Association 3
Family History
- Psychiatric disorders in biological relatives should be assessed, as per the American Psychiatric Association's guidelines 4
- History of suicidal behaviors in relatives (especially for patients with suicidal ideation) should be evaluated, following the American Psychiatric Association's recommendations 4
Personal and Social History
- Psychosocial stressors (financial, housing, legal, occupational, relationship problems) should be identified, as suggested by the American Psychiatric Association 4
- Trauma history should be assessed, according to the American Psychiatric Association's guidelines 4
Physical Examination
- Height, weight, and BMI should be measured, as per the American Psychiatric Association's guidelines 5
- Vital signs should be recorded, following the American Psychiatric Association's recommendations 5
Mental Status Examination
- Appearance and behavior should be assessed, as suggested by the American Psychiatric Association 5
- Speech (fluency and articulation) should be evaluated, according to the American Psychiatric Association's guidelines 5
- Mood and affect should be identified, following the American Psychiatric Association's recommendations 5
- Thought process (logical, tangential, circumstantial, etc.) should be assessed, as per the American Psychiatric Association's guidelines 5
Risk Assessment
- Current suicidal ideas, plans, and attempts should be evaluated, as suggested by the American Psychiatric Association 5
- Current aggressive or psychotic ideas should be assessed, according to the American Psychiatric Association's guidelines 5
- Documented estimate of suicide risk with influencing factors should be provided, following the American Psychiatric Association's recommendations 5
Impression and Plan
- Diagnostic formulation should be based on a comprehensive assessment, as recommended by the American Psychiatric Association 3
- Treatment plan with rationale should be developed, according to the American Psychiatric Association's guidelines 3
- Patient's treatment preferences should be considered, as suggested by the American Psychiatric Association 3
- Disposition plan (level of care determination) should be based on a comprehensive assessment, following the guidelines of the American Academy of Pediatrics 6
Special Considerations
- For patients with suicidal ideation, safety planning rather than no-suicide contracts should be used, as recommended by the American Academy of Pediatrics 6
- For patients with aggression, specific assessment of triggers and response to interventions should be conducted, according to the guidelines of the American Academy of Child and Adolescent Psychiatry 7
Documentation Requirements
- All sections should be clearly documented with date and time, as per the American Psychiatric Association's guidelines 3
- Authentication by the evaluating clinician should be provided, following the American Psychiatric Association's recommendations 3
Structured Guidelines for Psychiatric Interviewing of Young Adults
Consent and Confidentiality
- The American Academy of Child and Adolescent Psychiatry advises that clinicians must explain that all information shared during the interview will remain confidential except when there is a risk of harm to the patient or others, in which case disclosure is required for safety. 8
- Patients should be given an explicit opportunity to ask questions and must confirm that they understand the purpose and nature of the psychiatric assessment. 9
- For individuals aged 20 years, consent should be obtained directly from the patient, as they are legally an adult. 8
- The consent discussion must include:
- the purpose of the evaluation (e.g., diagnostic clarification, treatment planning) — 9, 10
- how the collected information will be used (clinical decision‑making, billing, research) — 9
- the limits of confidentiality specifically related to safety concerns (e.g., suicidal or homicidal risk) — 8
- who will have access to the information (treating team, authorized records) — 9
Medical and Neurological Screening
- Screening for sleep‑related breathing problems (e.g., snoring, upper‑airway obstruction) should be performed to identify possible obstructive sleep apnea, which can exacerbate psychiatric symptoms. 10
- A focused neurological review should assess for a history of seizures, head injuries, or loss of consciousness, as these conditions may influence mental‑health presentation and treatment choices. 11
Medication‑Related Considerations
- Clinicians must recognize that certain psychotropic agents—specifically lithium, valproic acid, and clozapine—can themselves produce psychiatric side‑effects; this should be documented and monitored. 10
Documentation of Prior Psychiatric Treatments
- A comprehensive record of all previous psychiatric medications (including drug name, dosage, duration, therapeutic response, side‑effects, and reasons for discontinuation) is required for safe medication management. 12
- Prior psychotherapy should be detailed (type, duration, perceived benefit) to inform continuity or modification of therapeutic approaches. 12
- Any past psychiatric hospitalizations (dates, reasons, length of stay, treatments received) must be captured to assess severity and treatment history. 12
- History of somatic treatments such as electroconvulsive therapy (ECT) should also be noted. 12
Developmental and Educational History
- The interview should include inquiry about prenatal and birth complications, as well as early developmental milestones (e.g., walking, talking, toilet training), because early neurodevelopmental events can affect later psychiatric risk. 11
- Early childhood behavior and temperament should be explored to identify patterns that may relate to current presentation. 11
- Academic history—including performance, grade retention, and receipt of special‑education services—provides context for functional impairment and may guide educational accommodations. 11
Diagnostic Formulation
- Given the high rate of misdiagnosis at illness onset, clinicians should perform periodic reassessment of the diagnostic formulation to ensure accuracy over time. 11
- When uncertainty exists, patients should be educated about the provisional nature of the diagnosis and the possibility of future revisions. 11
Pharmacologic Informed Consent
- Prior to initiating any medication, the clinician must obtain informed consent that covers:
- the specific symptoms targeted by the medication,
- expected benefits and typical timeline for clinical response,
- common and serious adverse effects,
- risks associated with not treating the condition,
- alternative therapeutic options (both pharmacologic and non‑pharmacologic),
- a monitoring plan outlining follow‑up frequency and assessment methods, and
- instructions for actions to take if problems arise (e.g., side‑effects, worsening symptoms).
Psychosocial Intervention Planning
- Evidence‑based psychotherapies such as cognitive‑behavioral therapy (CBT), dialectical behavior therapy (DBT), interpersonal therapy, or family therapy should be selected based on the patient’s diagnosis and needs, with clear specification of session frequency and total duration. 12
Documentation Standards
- The psychiatric interview record must be complete, dated, timed, and signed by the evaluating clinician to satisfy clinical decision‑making requirements and medical‑legal standards. 9
Ongoing Consent
- Consent is not a one‑time event; clinicians should revisit and reaffirm consent whenever treatment plans change (e.g., addition of new medication, shift to a different therapeutic modality). Ongoing consent discussions are essential for ethical practice. 9
Initial Psychiatric Assessment: Evidence‑Based Components
Symptom Evaluation
- Quantify the proportion of time the patient is preoccupied with psychiatric symptoms and evaluate the resulting psychosocial impairment to guide severity rating and treatment urgency. 13
Comprehensive Review of Systems
- Perform a systematic review of organ systems—including cardiopulmonary, endocrine, and infectious diseases such as sexually transmitted infections, HIV, tuberculosis, and hepatitis C—to identify medical contributors to psychiatric presentation. 13
Physical Examination
- Record anthropometric data (height, weight, body‑mass index) and vital signs (temperature, resting heart rate, blood pressure, orthostatic pulse and blood pressure) as baseline measures for monitoring treatment effects and medical risk. 13
- Inspect physical appearance for evidence of malnutrition or purging behaviors, which may indicate eating‑disorder pathology or other medical complications. 13
Laboratory and Diagnostic Testing
- Obtain a complete blood count and a comprehensive metabolic panel (electrolytes, liver enzymes, renal function) in every patient to detect metabolic abnormalities that can mimic or exacerbate psychiatric symptoms. 13
- Conduct an electrocardiogram in individuals with restrictive eating disorders, severe purging behaviors, or who are receiving medications known to prolong the QT interval, to screen for cardiac arrhythmia risk. 13
Treatment Planning
- Develop a documented, comprehensive, culturally appropriate, person‑centered treatment plan that integrates medical, psychiatric, psychological, and nutritional expertise, typically delivered by a coordinated multidisciplinary team. 13